Boston Partners - BIOSPECIFICS TECHNOLOGIES CO ownership

BIOSPECIFICS TECHNOLOGIES CO's ticker is BSTC and the CUSIP is 090931106. A total of 117 filers reported holding BIOSPECIFICS TECHNOLOGIES CO in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Boston Partners ownership history of BIOSPECIFICS TECHNOLOGIES CO
ValueSharesWeighting
Q3 2020$1,858,000
-31.6%
35,169
-20.7%
0.00%
-40.0%
Q2 2020$2,716,000
+2.0%
44,323
-5.9%
0.01%0.0%
Q1 2020$2,664,000
+10.2%
47,098
+10.9%
0.01%
+150.0%
Q4 2019$2,417,00042,4510.00%
Other shareholders
BIOSPECIFICS TECHNOLOGIES CO shareholders Q2 2020
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 211,370$9,833,0005.80%
JW Asset Management, LLC 73,649$3,426,0002.51%
NORTHPOINTE CAPITAL LLC 135,657$6,311,0000.67%
Elk Creek Partners, LLC 170,102$7,913,0000.50%
RICE HALL JAMES & ASSOCIATES, LLC 156,167$7,265,0000.32%
Ativo Capital Management LLC 22,592$1,051,0000.28%
Matarin Capital Management, LLC 59,077$2,748,262,0000.23%
ISTHMUS PARTNERS, LLC 16,753$779,0000.22%
CADENCE CAPITAL MANAGEMENT LLC 29,586$1,376,0000.09%
ALGERT GLOBAL LLC 7,834$364,0000.08%
View complete list of BIOSPECIFICS TECHNOLOGIES CO shareholders